Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

BUY
$35.33 - $55.79 $151,777 - $239,673
4,296 New
4,296 $239,000
Q2 2022

Aug 05, 2022

BUY
$36.95 - $82.41 $62,741 - $139,932
1,698 Added 41.21%
5,818 $263,000
Q1 2022

May 12, 2022

BUY
$55.7 - $145.79 $55,365 - $144,915
994 Added 31.8%
4,120 $313,000
Q4 2021

Feb 10, 2022

BUY
$135.05 - $182.59 $422,166 - $570,776
3,126 New
3,126 $466,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Citizens Financial Group Inc Portfolio

Follow Citizens Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Financial Group Inc with notifications on news.